Stay updated on Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Sign up to get notified when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.

Latest updates to the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page
- Check4 days agoChange DetectedThe page shows a minor revision update (Revision: v3.3.4) replacing the previous version v3.3.3 without affecting the core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedNew study locations were added across multiple countries (US, Argentina, Australia, Brazil, Canada, Denmark, France, Germany, Italy, Spain, Japan, China, etc.), expanding geographic coverage for the trial. Concurrently, several location entries were removed and the revision updated to v3.3.3.SummaryDifference0.9%

- Check54 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision tag from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the banner about the government funding lapse and NIH operating status; this administrative change does not affect study details or trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check83 days agoChange DetectedExternal information links to MedlinePlus Genetics, DailyMed, PubMed, and NIH/NLM pages were removed from the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check104 days agoChange Detected- Added a government-operations notice about potential delays and current status, plus links for updates. - Updated version to v3.2.0. - Removed the previous v3.1.0 reference.SummaryDifference2%

Stay in the know with updates to Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.